Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomesMaría Agustina Perusini, Dennis Dong Hwan Kim, Jaeyoon Kim et al.|Blood Advances|2024Cited by 14
Somatic mutations in myeloid transcription factors and in activated signaling genes predict the risk of treatment failure and progression to advanced phase in chronic myeloid leukemiaDennis Dong Huan Kim, Jiří Mayer, María Agustina Perusini et al.|Research Square|2023Cited by 0
Final Report: Somatic Mutations and HMGCLL1 Haplotype Are Not Associated with Molecular Relapse-Free Survival in Patients with Chronic Myeloid Leukemia Who Attempt Treatment-Free RemissionMaría Agustina Perusini, Dennis Dong Hwan Kim, Kátia Bórgia Barbosa Pagnano et al.|Blood|2023Cited by 0
New Pattern of Emerging Somatic Mutations in Optimal Responders Following Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia Patients Evidenced from Mutational Kinetic Analysis Based on Pairwise ComparisonGopila Gupta, Dennis Dong Hwan Kim, May Chiu et al.|Blood|2023Cited by 0